跳至主要内容
临床试验/NCT03052855
NCT03052855已完成不适用

Title: Inflammatory Biomarkers and Brain Metabolites, a Study Based on Magnetic Resonance Spectroscopy.

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2017年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
1
主要终点
Glutamine (Glu) and Glutamate (Glx) levels

研究概览

简要总结

Suicidal behaviors (SB) are a major health problem in France : 10 000 suicides and 220 000 suicide attempts every year. SB management is therefore a major public health issue.

Evidence associated dysregulation of the serotonergic system and the hypothalamic-pituitary-adrenal axis to vulnerability to SB. Recent data point to linke these abnormalities with neuroinflammatory clues, glutamatergic function and neuronal plasticity. There is a need to better understand the physiopathology and develop diagnostic and therapeutic tools in SB.

The investigators hypothesize that increased peripheral biomarkers of inflammation would correlate to a disturbance of the cerebral metabolites, such as glutamate and NAA, especially in suicidal patients.

Our aim is to compare rates of cerebral metabolites, in particular the complex glutamine/glutamate, in cerebral areas involved in suicidal vulnerability (the anterior cingulate cortex and the orbito-frontal cortex) between person with unipolar disorder with and without suicidal attempt.

详细描述

69 patients : 23 with suicidal thoughts and attempt, 23 with suicidal thoughts without attempt and 23 healthy volunteers.

2 visits :

  • Inclusion visit (V0) : (Day 1)

o Clinical interview : self and hetero assessment questionnaire

  • Visit V1 (as soon as possible, day 1 if available) :

  • MRI (spectroscopy)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Non-specific inclusion criteria:
  • •Having signed informed consent
  • •Able to understand nature, aims and methodology of the study
  • •Specific inclusion criteria :
  • •Suicidal patient with suicide attempt :
  • •Persistent depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders - V (DSM-V) criteria, and evaluated by the Mini International Neuropsychiatric Interview (MINI)
  • •Hamilton Depression Scale > 7
  • •Suicide attempt < 1 week
  • •Suicidal patient without suicide attempt :
  • •Persistent depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders - V (DSM-V) criteria, and evaluated by the Mini International Neuropsychiatric Interview (MINI)
  • •Hamilton Depression Scale > 7
  • •No history of suicide attempt
  • •Healthy volunteers :
  • •No psychiatric history
  • •No history of suicide attempt

排除标准

  • •Actual somatic, neurological or inflammatory pathology (C-Reactive Protein > 10mg/L)
  • •Traumatic brain injury with loss of consciousness
  • •Antibiotic treatment or anti-inflammatory treatment
  • •Actual toxic abuse according to DSM-V (except tobacco and alcohol)
  • •Actual or passed history of psychotic disorder
  • •Patient on protective measures (guardianship or trusteeship)
  • •Deprived of liberty subject (judicial or administrative decision)
  • •Pregnant women or breastfeeding
  • •Contraindications to MRI scan

研究组 & 干预措施

Participants

Other

All the participants of the 3 groups (depressed patients with suicide attempt, depressed patients without suicide attempt, healthy volunteers) will have to realize a MRI and biological samples.

干预措施: Magnetic Resonance Imaging (MRI) and biological samples (Other)

结局指标

主要结局

Glutamine (Glu) and Glutamate (Glx) levels

时间窗: At V1 (the day of the MRI)

Levels of Glu/Glx in the anterior cingulate cortex and the orbitofrontal cortex between the depressed patients with and without suicide attempt

次要结局

  • Link between rate of Interleukin 1, 2, 4, 5, 6, 7, 9, 10, 13 and suicide attempt(At V1 (the day of the MRI))
  • Level of N-Acetyl-Aspartate (NAA)(At V1 (the day of the MRI))
  • Level of Choline (Cho)(At V1 (the day of the MRI))
  • Level of Myo-inositol (Myo)(At V1 (the day of the MRI))
  • Level of Creatinine (Cr)(At V1 (the day of the MRI))
  • Link between level of depression self assessed with the Beck Scale and metabolites levels(At V1 (the day of the MRI))
  • Link between level of suicidal intentionality assessed by the Columbia Suicide Severity Rating Scale (CSS-RS) and metabolites levels(At V1 (the day of the MRI))
  • Link between level of depression assessed by the clinician with the Hamilton Rating Scale (HAMD) and metabolite levels(At V1 (the day of the MRI))
  • Link between rate of Tumor necrosis factor alpha (TNF α) and suicide attempt(At V1 (the day of the MRI))
  • Link between rate of Tumor necrosis factor beta (TNFβ) and suicide attempt(At V1 (the day of the MRI))
  • Link between rate of Interferon gamma (IFNγ) and suicide attempt(At V1 (the day of the MRI))
  • Link between rate of C-Reactive Protein (CRP) and suicide attempt(At V1 (the day of the MRI))
  • Link between rate of Interferon Gamma Inducing Factors (IGIF)and suicide attempt(At V1 (the day of the MRI))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验